AZN icon

AstraZeneca

92.57 USD
+0.12
0.13%
At close Updated Dec 26, 12:03 PM EST
1 day
0.13%
5 days
2.37%
1 month
-0.8%
3 months
25.5%
6 months
32.11%
Year to date
40.51%
1 year
39.16%
5 years
87.46%
10 years
171.55%
 

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Employees: 94,300

0
Funds holding %
of 7,526 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™